missing translation for 'onlineSavingsMsg'
Learn More

NUP62CL Antibody (S08-1A5), Novus Biologicals™

Rabbit Monoclonal Antibody

€ 421.00 - € 645.00

Specifications

Antigen NUP62CL
Clone S08-1A5
Concentration 0.3 mg/mL
Applications Western Blot
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18637433
View Documents
Novus Biologicals
NBP3-19818-50ul
50 μg
€ 421.00
50µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18608573
View Documents
Novus Biologicals
NBP3-19818-100ul
100 μg
€ 645.00
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

NUP62CL Monoclonal antibody specifically detects NUP62CL in Human samples. It is validated for Western Blot
Specifications

Specifications

NUP62CL
0.3 mg/mL
Monoclonal
Purified
RUO
Human
FLJ20130, nucleoporin 62kDa C-terminal like, nucleoporin-62 C-terminal-like protein, NUP62L
A synthetic peptide of human NUP62CL (Uniprot # Q9H1M0)
Primary
Store at 4°C short term. Store at -20°C long term. Avoid freeze-thaw cycles.
S08-1A5
Western Blot
Unconjugated
Rabbit
DNA replication Transcription Translation and Splicing
50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.05% BSA
54830
IgG
Affinity purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.